UTHR logo

United Therapeutics Corporation (UTHR)

Profile

Full Name

United Therapeutics Corporation

Ticker

NASDAQ: UTHR

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

June 17, 1999

Indexes

Not included

Website

http://www.unither.com

Employees

1305

Key Details

Price

$304.50(-0.62%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.88B(+23.63% YoY)

Annual EPS

$24.64(+24.38% YoY)

PE ratio

12.15

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $304.50
    UTHR price is $304.50

    30-Day Relative Volume

    0.63
    UTHR 30-day relative volume is 0.63

    Price Performance

    Price Most recent change

    -0.62%
    UTHR price was down -0.62% on Jul 25, 2025

    Price YTD change

    -13.7%
    UTHR price is down -13.7% since January 1st

    Price 1-year change

    -9.47%
    UTHR price is down -9.47% year-on-year

    Price 3-year change

    +33.56%
    UTHR price is up +33.56% over the past 3 years

    Price Range

    Price All-time high

    $417.82
    UTHR price is currently -27.12% below its historical high of $417.82

    Price 3-year low

    $201.65
    UTHR price is currently +51.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $13.73B
    UTHR market capitalization is $13.73 billion

    Market cap 3-year change

    +32.44%
    UTHR market capitalization is up +32.44% over the past 3 years

    Market cap All-time high

    $18.28B
    UTHR market capitalization is currently -24.87% below its historical high of $18.28 billion

    Market cap sector rank

    93.9%
    UTHR market capitalization is higher than 93.9% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.38%
    UTHR shares outstanding is up +1.38% year-on-year

    Shares Outstanding 3-Year Change

    -0.84%
    UTHR shares outstanding is down -0.84% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.56
    UTHR beta is 0.56

    200-day SMA

    $332.73
    UTHR price is currently -8.49% below its 200-day simple moving average

    50-day SMA

    $300.36
    UTHR price is currently +1.38% above its 50-day simple moving average

    RSI

    57.10
    UTHR 14-day relative strength index is 57.10

    Volume

    0.63
    UTHR 30-day relative volume is 0.63

    ATR

    $7.22
    UTHR average true range is $7.22

    10-day Historical Volatility

    22.37%
    UTHR 10-day historical volatility is 22.37%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.88B
    UTHR annual revenue is $2.88 billion

    Revenue Analysts estimate

    $3.23B
    UTHR annual revenue is currently -10.88% lower than the consensus analysts' forecast

    Revenue 1-year change

    +23.63%
    UTHR annual revenue is up +23.63% year-on-year

    Revenue Sector rank

    88%
    UTHR annual revenue is higher than 88% of companies in Healthcare sector

    EPS

    EPS

    $24.64
    UTHR annual earnings per share is $24.64

    EPS Analysts estimate

    $27.26
    UTHR annual earnings per share is currently -9.61% lower than the consensus analysts' forecast

    EPS 1-year change

    +24.38%
    UTHR annual earnings per share is up +24.38% year-on-year

    EPS Sector rank

    99.34%
    UTHR annual earnings per share is higher than 99.34% of companies in Healthcare sector

    Profit

    Gross profit

    $2.57B
    UTHR annual gross profit is $2.57 billion

    Gross margin

    89.24%
    UTHR annual gross profit margin is 89.24%

    Operating profit

    $1.45B
    UTHR annual operating income is $1.45 billion

    Operating margin

    50.33%
    UTHR annual operating profit margin is 50.33%

    Net income

    $1.20B
    UTHR annual net profit is $1.20 billion

    Net margin

    41.53%
    UTHR annual net profit margin is 41.53%

    Expenses

    Total expenses

    $1.43B
    UTHR annual total expenses is $1.43 billion

    Operating expenses

    $1.12B
    UTHR annual total operating expenses is $1.12 billion

    Cost of goods sold

    $309.70M
    UTHR annual cost of goods sold is $309.70 million

    Selling, general & administrative expenses

    $638.60M
    UTHR annual SGA is $638.60 million

    Depreciation and amortization

    $72.50M
    UTHR annual depreciation & amortization is $72.50 million

    Interest expense

    $42.90M
    UTHR annual interest expense is $42.90 million

    Income tax

    $343.90M
    UTHR annual income tax is $343.90 million

    EBIT & EBITDA

    EBIT

    $1.58B
    UTHR annual earnings before interest & taxes is $1.58 billion

    EBITDA

    $1.65B
    UTHR annual EBITDA is $1.65 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $7.36B
    UTHR annual total assets is $7.36 billion

    Non current assets

    $3.49B
    UTHR annual long term assets is $3.49 billion

    Current assets

    $3.87B
    UTHR annual total current assets is $3.87 billion

    Cash and cash equivalents

    $1.70B
    UTHR annual cash & cash equivalents is $1.70 billion

    Accounts receivable

    $279.30M
    UTHR annual accounts receivable is $279.30 million

    Inventory

    $157.90M
    UTHR annual inventory is $157.90 million

    Liabilities

    Total liabilities

    $920.00M
    UTHR annual total liabilities is $920.00 million

    Long term liabilities

    $181.90M
    UTHR annual total long term liabilities is $181.90 million

    Current liabilities

    $738.10M
    UTHR annual total current liabilities is $738.10 million

    Accounts payable

    $6.00M
    UTHR annual accounts payable is $6.00 million

    Debt

    Total debt

    $300.00M
    UTHR annual total debt is $300.00 million

    Total debt 1-year change

    -57.14%
    UTHR annual total debt is down -57.14% year-on-year

    Long term debt

    -
    UTHR annual long term debt value is unknown

    Short term debt

    $300.00M
    UTHR annual short term debt is $300.00 million

    Equity & Capital

    Shareholders equity

    $6.44B
    UTHR annual stockholders equity is $6.44 billion

    Book value

    $6.44B
    UTHR annual book value is $6.44 billion

    Retained earnings

    $7.22B
    UTHR annual retained earnings is $7.22 billion

    Working capital

    $3.14B
    UTHR annual working capital is $3.14 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $1.33B
    UTHR annual cash flow from operations is $1.33 billion

    Cash from operations 1-year change

    +35.7%
    UTHR annual cash flow from operations is up +35.7% year-on-year

    Cash from investing

    $417.20M
    UTHR annual cash flow from investing activities is $417.20 million

    Cash from investing 1-year change

    +157.98%
    UTHR annual cash flow from investing activities is up +157.98% year-on-year

    Cash from financing

    -$1.25B
    UTHR annual cash flow from financing activities is -$1.25 billion

    Cash from financing 1-year change

    -10444.54%
    UTHR annual cash flow from financing activities is down -10444.54% year-on-year

    CAPEX

    CAPEX

    $246.50M
    UTHR annual capital expenditures is $246.50 million

    CAPEX 1-year change

    +6.99%
    UTHR annual capital expenditures is up +6.99% year-on-year

    Free Cash Flow

    Free cash flow

    $1.08B
    UTHR annual free cash flow is $1.08 billion

    Free cash flow 1-year change

    +44.54%
    UTHR annual free cash flow is up +44.54% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    89.24%
    UTHR annual gross profit margin is 89.24%

    Operating margin

    50.33%
    UTHR annual operating profit margin is 50.33%

    Net margin

    41.53%
    UTHR annual net profit margin is 41.53%

    ROA & ROE

    ROA

    16.45%
    UTHR annual return on assets is 16.45%

    ROE

    19.23%
    UTHR annual return on equity is 19.23%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    12.15
    UTHR price to earnings ratio is 12.15

    PE ratio Sector rank

    18.4%
    UTHR price to earnings ratio is higher than 18.4% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.02
    UTHR price to book ratio is 2.02

    PB ratio Sector rank

    55.09%
    UTHR price to book ratio is higher than 55.09% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.59
    UTHR price to sales ratio is 4.59

    PS ratio Sector rank

    59.87%
    UTHR price to sales ratio is higher than 59.87% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $12.04B
    UTHR enterprise value is $12.04 billion

    Enterprise value Sector rank

    92.91%
    UTHR enterprise value is higher than 92.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    7.18
    UTHR EV/EBITDA is 7.18

    EV/EBITDA Sector rank

    79.67%
    UTHR EV/EBITDA is higher than 79.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.25
    UTHR annual current ratio is 5.25

    Quick ratio

    5.03
    UTHR annual quick ratio is 5.03

    Leverage

    Debt to equity

    0.05
    UTHR annual debt to equity ratio is 0.05

    Interest coverage ratio

    36.87
    UTHR annual interest coverage ratio is 36.87

    Risk & Stability

    Piotroski F-Score

    -
    UTHR piotroski f-score value is unknown

    Altman Z-Score

    11.94
    UTHR altman z-score is 11.94

    Analyst ratings

    Recent major analysts updates

    Jul 10, 25 Morgan Stanley
    Equal-Weight
    Jul 8, 25 JP Morgan
    Overweight
    Jun 30, 25 UBS
    Buy
    Jun 11, 25 B of A Securities
    Neutral
    Jun 2, 25 Cantor Fitzgerald
    Overweight
    May 5, 25 HC Wainwright & Co.
    Buy
    May 1, 25 Morgan Stanley
    Equal-Weight
    May 1, 25 JP Morgan
    Overweight
    May 1, 25 B of A Securities
    Neutral
    Apr 25, 25 Wells Fargo
    Equal-Weight

    Institutional Ownership

    Screeners with UTHR included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for United Therapeutics Corporation?
    • Does United Therapeutics Corporation pay dividends?
    • What sector is United Therapeutics Corporation in?
    • What industry is United Therapeutics Corporation in?
    • What country is United Therapeutics Corporation based in?
    • When did United Therapeutics Corporation go public?
    • Is United Therapeutics Corporation in the S&P 500?
    • Is United Therapeutics Corporation in the NASDAQ 100?
    • Is United Therapeutics Corporation in the Dow Jones?
    • When was United Therapeutics Corporation's last earnings report?
    • When does United Therapeutics Corporation report earnings?

    What is the ticker symbol for United Therapeutics Corporation?

    The ticker symbol for United Therapeutics Corporation is NASDAQ:UTHR

    Does United Therapeutics Corporation pay dividends?

    No, United Therapeutics Corporation does not pay dividends

    What sector is United Therapeutics Corporation in?

    United Therapeutics Corporation is in the Healthcare sector

    What industry is United Therapeutics Corporation in?

    United Therapeutics Corporation is in the Specialty & Generic Drug Manufacturers industry

    What country is United Therapeutics Corporation based in?

    United Therapeutics Corporation is headquartered in United States

    When did United Therapeutics Corporation go public?

    United Therapeutics Corporation's initial public offering (IPO) was on June 17, 1999

    Is United Therapeutics Corporation in the S&P 500?

    No, United Therapeutics Corporation is not included in the S&P 500 index

    Is United Therapeutics Corporation in the NASDAQ 100?

    No, United Therapeutics Corporation is not included in the NASDAQ 100 index

    Is United Therapeutics Corporation in the Dow Jones?

    No, United Therapeutics Corporation is not included in the Dow Jones index

    When was United Therapeutics Corporation's last earnings report?

    United Therapeutics Corporation's most recent earnings report was on April 30, 2025

    When does United Therapeutics Corporation report earnings?

    The next expected earnings date for United Therapeutics Corporation is July 30, 2025
    On this page